Evaluate the Safety of BEL-X-HG in Advanced Cancer Patients
Clinical trial NCT03256331 · TERMINATED
Trial details
- NCT number
- NCT03256331
- Sponsor
- Belx Bio-Pharmaceutical (Taiwan) Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2020-03-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.